Literature DB >> 29628281

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29628281     DOI： 10.1016/j.jhep.2018.03.019

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  1563 in total

1.  An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.

Authors:  Xiu-Ping Zhang; Kang Wang; Xu-Biao Wei; Le-Qun Li; Hui-Chuan Sun; Tian-Fu Wen; Zong-Tao Chai; Zhen-Hua Chen; Jie Shi; Wei-Xing Guo; Dong Xie; Wen-Ming Cong; Meng-Chao Wu; Wan Yee Lau; Shu-Qun Cheng
Journal:  Oncologist       Date:  2019-05-28

2.  Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma: a retrospective study.

Authors:  Mengmeng Feng; Mengchao Zhang; Yuanqing Liu; Nan Jiang; Qian Meng; Jia Wang; Ziyun Yao; Wenjuan Gan; Hui Dai
Journal:  BMC Cancer       Date:  2020-06-30       Impact factor: 4.430

Review 3.  The Impact of Translational Research in Hepatology.

Authors:  Johann von Felden; Amanda J Craig; Augusto Villanueva
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-02-21

4.  Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.

Authors:  Dong Ho Lee; Jeong Min Lee; Pyo Nyun Kim; Yun-Jin Jang; Tae Wook Kang; Hyunchul Rhim; Jung Wook Seo; Young Joon Lee
Journal:  Eur Radiol       Date:  2019-02-15       Impact factor: 5.315

Review 5.  Emerging Role of the Pathologist in Precision Medicine for HCC.

Authors:  Thomas Longerich; Peter Schirmacher
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

6.  Assessment of the effect of the Aquamantys® system on local recurrence after hepatectomy for hepatocellular carcinoma through propensity score matching.

Authors:  M H Sui; H G Wang; M Y Chen; T Wan; B Y Hu; Y W Pan; H Li; H Y Cai; C Cui; S C Lu
Journal:  Clin Transl Oncol       Date:  2019-03-25       Impact factor: 3.405

7.  Objective Response by mRECIST Is an Independent Prognostic Factor of Overall Survival in Systemic Therapy for Hepatocellular Carcinoma.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2019-02-27       Impact factor: 11.740

Review 8.  Challenges in Diagnosis of Hepatocellular Carcinoma in Cirrhotic Liver: A Pathologist's Perspective.

Authors:  Dana Balitzer; Sanjay Kakar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

Review 9.  Role of US LI-RADS in the LI-RADS Algorithm.

Authors:  Shuchi K Rodgers; David T Fetzer; Helena Gabriel; James H Seow; Hailey H Choi; Katherine E Maturen; Ashish P Wasnik; Tara A Morgan; Nirvikar Dahiya; Mary K O'Boyle; Yuko Kono; Claude B Sirlin; Aya Kamaya
Journal:  Radiographics       Date:  2019 May-Jun       Impact factor: 5.333

10.  Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Authors:  Jordi Rimola; Alejandro Forner; Víctor Sapena; Neus Llarch; Anna Darnell; Alba Díaz; Angeles García-Criado; Lluís Bianchi; Ramon Vilana; Álvaro Díaz-González; Carmen Ayuso; Jordi Bruix; María Reig
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.